Related Experiment Video
Updated: Jun 11, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
[Sleep disorders in women: diagnostic and treatment considerations]
M V Bochkarev1, Yu V Sviryaev1
1Almazov National Medical Research Centre, St. Petersburg, Russia.
Abstract:
This review consolidates current findings concerning the epidemiology, pathophysiology, and clinical characteristics of sleep disorders in women. The discussion encompasses gender disparities in sleep architecture and circadian rhythms, as well as the influence of reproductive stages - including the menstrual cycle, pregnancy, and menopause - on the emergence and progression of disorders such as insomnia, restless legs syndrome, snoring, obstructive sleep apnea, hypersomnias, and parasomnias. Special emphasis is placed on diagnostic and therapeutic approaches that address physiological changes throughout various stages of a woman's life, particularly during pregnancy and lactation. The necessity for a personalized approach and interdisciplinary collaboration for the prompt diagnosis and effective treatment of these conditions is underscored.
More Related Videos
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Disorders of the Female Reproductive System
Narcolepsy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...